Cor Vasa 2008, 50(6):242-245 | DOI: 10.33678/cor.2008.080
Our initial experience with genetic testing of patients with hypertrophic cardiomyopathy: mutations of troponin T and troponin I genes
- 1 III. interní-kardiologická klinika, Kardiocentrum, Fakultní nemocnice Královské Vinohrady a 3. lékařská fakulta Univerzity Karlovy
- 2 Laboratoř molekulární genetiky Genomac International, s. r. o., Praha, Česká republika
Introduction:
Hypertrophic cardiomyopathy (HCM) is an autosomal hereditary dominant disorder caused by mutations in genes encoding cardiac sarcomeric proteins. Troponin T and troponin I make an important part of the heart muscle sarcomere and mutations in their genes are responsible for developing HCM. The frequency of these 2 genes is reported to be about 3-15%.
Method:
We studied the prevalence of mutations in troponin T and troponin I genes in 40 individuals with HCM on follow-up in the Heart Center of a Prague-based hospital. DNA samples were genetically tested using direct bidirectional sequencing of PCR products. Genetic testing was performed in exons 8-11 and 14-16 in TNNT2 and exons 5, 7, and 8 in TNNI3.
Results:
The disease causing mutation was found in 3 (7.5%) patients. All mutations were present only in the troponin I gene, in exon 7 (2 x Arg141Gln and 1 x Ala157Val). Further genetic testing identified a total of another 4 mutation carriers in the affected families. The subjects were characterized by mild symptoms and moderate left ventricular hypertrophy (mean maximum septal wall thickness 23 ± 3 mm). An increased incidence od sudden cardiac death, both in young and adult age, was observed in a family with the Ala157Val mutation.
Conclusion:
We observed a higher incidence (7.5%) of troponin I gene mutations and no mutation in the troponin T gene in our group of HCM patients. While patients with mutations were characterized by mild symptoms, an increased risk for sudden death was noted in the family with the Ala157Val mutation.
Keywords: Hypertrophic cardiomyopathy; Genes; Mutations; Troponin I; Troponin T
Published: June 1, 2008 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Gregor P, Widimský P, Anděl M, et al. Kardiologie. Praha: Galén, 1999:595,449.
- Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrofic cardiomyopathy in a general population of jung adult: echokardiographic analysis of 4111 subject in KARDIA study. Circulation 1995;92:785-9.
Go to original source...
Go to PubMed...
- http://genetics.med.harvard.edu/~seidman/cg3/index.html
- Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy. Distribution of disease genes, spectrum of mutations and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-32.
Go to original source...
Go to PubMed...
- Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and - tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332:1058-64.
Go to original source...
Go to PubMed...
- Mogensen J, Murphy RT, Kubo T, et al. Freguency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2315-25.
Go to original source...
Go to PubMed...
- Van Driest SL, Ellsworth EG, Ommen SR, et al. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003;108:445-51.
Go to original source...
Go to PubMed...
- Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
Go to original source...
Go to PubMed...
- Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348:295-303.
Go to original source...
Go to PubMed...
- McKenna WJ, Sharma S and Elliot PM. Management strategies in hypertrophic cardiomyopathy: influence of age and morphology. Eur Heart 2001;3 (Suppl L): L10-L14.
Go to original source...
- Maron BJ, McKenna WJ, Danielson GK, et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 2003;42: 1965-91.
Go to original source...
- Brito D, Madeira H. Malignant mutations in hypertrophic cardiomyopathy: fact or fancy? Rev Port Cardiol 2005; 24:1137-46.
Go to PubMed...